Author:
Stangl R.,Altendorf-Hofmann A.,Scheele J.
Publisher
Springer Berlin Heidelberg
Reference31 articles.
1. Balch CM, Urist MM, Soong SJ, McGregor ML (1983) A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 198: 567–573
2. Bedikian AY, Chen TT, Malahy MA, Patt YZ, Bodey GP (1984) Prognostic factors influencing survival of patients with advanced colorectal cancer: hepatic-artery infusion versus systemic intravenous chemotherapy for liver metastases. J Clin Oncol 2: 174–180
3. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM (1987) A prospective randomized trial of regional versus systemic continous 5fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206: 685–693
4. Chang AE, Steinberg SM, Culnane M, White DE (1989) Determinants of survival in patients with unresectable colorectal liver metastases. J Surg Oncol 40: 245–251
5. Ekberg H, Tranberg KG, Lundstedt C, Hanff G, Ranstam J, Jeppson B, Bengmark S (1986) Determinants of survival after intraarterial infusion of 5-Fluorouracil for liver metastases from colorectal cancer: A multivariate analysis. J Surg Oncol 31: 246–254